Equities

Creightons PLC

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Creightons PLC

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (GBX)28.00
  • Today's Change1.00 / 3.70%
  • Shares traded192.05k
  • 1 Year change-9.68%
  • Beta1.4960
Data delayed at least 20 minutes, as of Feb 13 2026 16:35 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Creightons Plc is engaged in the development, marketing, manufacture and supply of personal care, beauty and fragrance products, which includes the development of brands. The beauty products sector offers products for haircare, skincare, bath & body, male grooming and fine fragrances. Its operations are organized into three business streams: own branded business, private label business and contract manufacturing business. Its own branded business develops, markets, sells and distributes products developed and owns the rights to or brands it has licensed. The brands in the branded business include Feather and Down, Balance Active, The Curl Company, Emma Hardie and T-Zone. The private label business focuses on private-label products for high street retailers and supermarket chains, with most of the stock manufactured to forecast. Its contract manufacturing business develops and manufactures products on behalf of third-party brand owners and are typically manufactured to order.

  • Revenue in GBP (TTM)54.21m
  • Net income in GBP2.32m
  • Incorporated1975
  • Employees378.00
  • Location
    Creightons PLC1210 Lincoln RoadPETERBOROUGH PE4 6NDUnited KingdomGBR
  • Phone+44 173 328 1000
  • Fax+44 173 328 1028
  • Websitehttps://www.creightons.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Miraculum SA10.35m-420.46k7.36m49.00--1.26--0.7106-0.0429-0.04291.060.59520.85622.389.92945,903.60-3.48-5.81-4.69-8.4529.8932.57-4.06-8.390.3003-0.50170.3359--0.969516.91-120.02---30.96--
Harper Hygienics SA51.66m1.58m7.65m434.004.840.52332.590.14811.201.2039.3011.120.98435.003.51576,482.803.01--4.51--30.56--3.06--0.88332.690.5842--------------
Pharmena SA263.06k-412.35k7.93m7.00--3.65--30.16-0.1793-0.17930.11440.94640.10630.30352.40182,000.00-16.65-49.56-17.71-127.7184.5452.20-156.59-132.8312.58--0.0172---78.58-52.5192.91---7.99--
Clemondo Group AB (publ)23.29m520.90k10.01m61.0019.211.045.880.42960.45820.458220.498.461.413.667.544,890,966.003.167.414.6411.7938.0538.012.245.000.63968.080.3070.00-6.041.20-38.04--107.97--
Delko SA157.74m388.19k16.40m1.04k42.240.52134.300.1040.15720.157263.8812.742.260.157510.171,079,030.000.5558--0.9472--98.22--0.2461--0.6864272.470.3846---11.35---80.99------
Creightons plc54.21m2.32m19.19m378.008.850.76914.930.3540.03170.03170.74020.36411.383.423.92143,410.005.903.518.184.8945.0342.444.282.391.6724.700.105621.981.642.49169.52-4.99-34.87-5.11
Viking Kagit ve Seluloz AS12.79m-12.17m22.93m142.00--54.87--1.79-17.28-17.2818.150.5930.2563.894.514,484,666.00-24.38-10.04-144.90-40.3215.298.17-95.20-15.700.0787-0.19890.991---39.4529.30-722.97--35.23--
4Mass SA22.28m2.13m23.72m145.0010.991.378.151.060.43540.43544.543.491.101.1112.30811,147.0010.5219.7411.9222.8860.4356.589.5614.052.0321.280.0368--17.0454.89-3.58------
Bogart SA241.89m-8.55m49.12m1.91k--0.82012.240.2031-0.6712-0.671218.984.390.75541.1413.39136,032.80-2.66-0.1939-4.13-0.319852.3551.29-3.53-0.29190.39061.370.7717---1.29-0.9946-111.67--2.94-7.00
Culti Milano SpA20.20m3.23m50.60m61.0013.784.1111.862.511.361.368.524.571.041.475.12380,787.1016.4310.3627.1315.7254.5753.6115.7810.821.07--0.102612.669.3922.35187.3364.9718.844.56
Dr Miele Cosmed Group SA103.46m5.00m51.40m542.0010.180.91136.140.49680.28010.28015.813.131.184.738.52924,426.205.685.268.407.6541.7539.004.834.700.55026.670.1978--9.879.5361.9760.8349.37--
PCC Exol SA222.33m8.76m81.98m330.009.360.79546.580.36870.24360.24366.182.871.148.947.263,272,833.004.507.905.6610.6417.4819.403.946.531.013.890.366426.98-0.00958.22-15.644.700.4647--
Data as of Feb 13 2026. Currency figures normalised to Creightons PLC's reporting currency: UK Pound GBX

Institutional shareholders

20.16%Per cent of shares held by top holders
HolderShares% Held
Schroder Investment Management Ltd.as of 28 Jul 20257.55m11.02%
GPIM Ltd.as of 31 Mar 20255.06m7.39%
Attitude Gesti�n SGIIC SAas of 31 Dec 2025839.96k1.23%
Gesiuris Asset Management SGIIC SAas of 30 Jun 2025360.33k0.53%
More ▼
Data from 28 Nov 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.